This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thursday's Late Winners & Losers

Extended trading leaned to the negative side on Thursday thanks in part to a falling Apple (AAPL - Get Report), which was one of the most heavily traded stocks after the bell on its announcement of a major product delay .

The California-based computer giant said its new Leopard operating system won't be released until October -- at least three months after it had originally planned -- as a consequence of diverting resources to ensuring the timely release of its iPhone product. Shares were recently sinking $2.39, or 2.6%, to $89.80.

Another highly active stock after hours was Dyax (DYAX - Get Report), a biotech that catapulted 48% amidst positive late-phase preliminary results for DX-88, a proposed treatment for acute swelling and inflammation caused by hereditary angioedema. The study achieved all primary and secondary endpoints. Shares surged $1.92 to $5.92.

Meanwhile, North Carolina's Krispy Kreme Doughnuts (KKD - Get Report) slid 5% to $10.73 after posting a fiscal fourth-quarter loss of 39 cents a share on sales that dropped 8.2% to $112.2 million -- $11 million under the only analyst estimate from Thomson Financial.

California-based Varian Medical Systems (VAR), which focuses on cancer therapies, sank 5.7% to $46.14 after estimating only a 7% sales rise in the second fiscal quarter from last year -- about $442.9 million, roughly $11.4 million below Street targets.

Elsewhere, small-cap protective-garment maker Lakeland Industries (LAKE - Get Report) saw a 6-cent per-share drop from last year to 24 cents in the quarter ended Jan. 31, scaring shares down 9.7% to $13 in recent after-hours action.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AAPL $126.44 -0.13%
DYAX $26.31 -1.24%
KKD $19.15 -0.98%
LAKE $11.12 -2.03%
FB $87.28 0.43%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs